Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Malignant Neoplasm of Prostate”

372 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 372 results

Not applicableLooking for participantsNCT06700057
What this trial is testing

Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.

Who this might be right for
Prostate CancerMetastasis
Institut Bergonié 50
Not applicableUnknownNCT04851639
What this trial is testing

The Wolverhampton Assessment Tool, a Tool for Patient-reported Wellbeing in the Context of Prostate Cancer

Who this might be right for
Advanced Prostate Carcinoma
University of Wolverhampton 50
Testing effectiveness (Phase 2)Study completedNCT00140400
What this trial is testing

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys 50
Not applicableLooking for participantsNCT06546267
What this trial is testing

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 2,500
Large-scale testing (Phase 3)Study completedNCT00134056
What this trial is testing

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
SWOG Cancer Research Network 1,038
Not applicableEnded earlyNCT00918645
What this trial is testing

Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis

Who this might be right for
Metastatic CancerProstate Cancer
University of California, Davis 13
Not applicableWithdrawnNCT02742259
What this trial is testing

Validation of the Prostate Cancer Assay - Beta+Pivotal

Who this might be right for
Metastatic Prostate Cancer, CTC
Celsee Diagnostics
Testing effectiveness (Phase 2)Active Not RecruitingNCT03217747
What this trial is testing

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more
M.D. Anderson Cancer Center 173
Testing effectiveness (Phase 2)Ended earlyNCT04616547
What this trial is testing

Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Adenocarcinoma+3 more
National Cancer Institute (NCI) 1
Not applicableUnknownNCT02963155
What this trial is testing

Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration

Who this might be right for
Metastatic Prostate Cancer
Institut Paoli-Calmettes 30
Early research (Phase 1)Active Not RecruitingNCT04457232
What this trial is testing

Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation

Who this might be right for
Metastatic Malignant Neoplasm in the Prostate GlandProstate CarcinomaRecurrent Prostate Carcinoma
Jonsson Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Early research (Phase 1)Temporarily pausedNCT00909558
What this trial is testing

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Envita Medical Center, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT02903160
What this trial is testing

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 40
Testing effectiveness (Phase 2)Ended earlyNCT00887640
What this trial is testing

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 11
Not applicableStudy completedNCT00656305
What this trial is testing

ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain

Who this might be right for
Bone MetastasesMultiple Myeloma
InSightec 147
Early research (Phase 1)Ended earlyNCT01741753
What this trial is testing

BKM120+Abiraterone Acetate for Metastatic CRPC

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 4
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT04754425
What this trial is testing

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaCastration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted AgentsMetastatic Malignant Neoplasm in the Bone+5 more
M.D. Anderson Cancer Center 11
Not applicableUnknownNCT06117696
What this trial is testing

Optimizing the Announcement of Advanced or Metastatic Prostate Cancer Using Animated Videos (CartDiag PROSTATE)

Who this might be right for
Prostate Cancer
Direction Centrale du Service de Santé des Armées 90
Next Page